# Health Data Insight CIC

> Health Data Insight (HDI) use health data to improve patient care and outcomes by delivering national-scale analytics platforms, publishing applied research, and releasing practical tools that lower barriers to safe data exploration. 

We focus on cancer pathways and service quality, working alongside NHS England’s National Disease Registration Service (NDRS), charities, and clinical partners to translate data into actionable improvement.

Our Simulacrum synthetic cancer dataset broadens access to safe, representative test data so teams can prototype analyses, develop methods, and plan studies before applying for approved runs on the real data. This approach accelerates evidence generation, supports training, and reduces duplication of effort while protecting confidentiality.



## Pages

- [CCA organisational survey privacy notice](https://healthdatainsight.org.uk/cca-organisational-survey-privacy-notice/)
- [Request Counts](https://healthdatainsight.org.uk/request-counts/)
- [HDI Internships](https://healthdatainsight.org.uk/hdi-internships/)
- [Services](https://healthdatainsight.org.uk/services/)
- [Data Services](https://healthdatainsight.org.uk/data-services/)
- [Project Management](https://healthdatainsight.org.uk/project-management/)
- [Technology Solutions](https://healthdatainsight.org.uk/technology-solutions/)
- [Consultancy](https://healthdatainsight.org.uk/consultancy/)
- [Partnerships](https://healthdatainsight.org.uk/partnerships/)
- [Health Data Insight CIC](https://healthdatainsight.org.uk/)
- [HDI publications in association with NDRS](https://healthdatainsight.org.uk/hdi-publications-in-association-with-ndrs/)
- [All archived projects](https://healthdatainsight.org.uk/all-archived-projects/)
- [Publications](https://healthdatainsight.org.uk/publications/)
- [Careers](https://healthdatainsight.org.uk/careers/)
- [Privacy Policy](https://healthdatainsight.org.uk/privacy-policy/)
- [The Board](https://healthdatainsight.org.uk/the-board/)
- [News](https://healthdatainsight.org.uk/news/)
- [Information Governance](https://healthdatainsight.org.uk/information-governance/)
- [About](https://healthdatainsight.org.uk/about-hdi/)
- [Contact](https://healthdatainsight.org.uk/contact/)


## Posts

- [New project launches to improve understanding of cholangiocarcinoma care across the UK](https://healthdatainsight.org.uk/new-project-launches-to-improve-understanding-of-cholangiocarcinoma-care-across-the-uk/)
- [Third Endometrial Cancer Audit Pilot (ECAP) Report published](https://healthdatainsight.org.uk/third-endometrial-cancer-audit-pilot-ecap-report-published/)
- [New Project Launch: Post Imaging Pancreatic Cancer Root Cause Analysis (PIPC)](https://healthdatainsight.org.uk/new-project-launch-post-imaging-pancreatic-cancer-root-cause-analysis-pipc/)
- [Development of a national root cause analysis system for post-endoscopy upper gastrointestinal cancer](https://healthdatainsight.org.uk/development-of-a-national-root-cause-analysis-system-for-post-endoscopy-upper-gastrointestinal-cancer/)
- [New research highlights how cancer stage at diagnosis impacts NHS hospital care costs](https://healthdatainsight.org.uk/new-research-highlights-how-cancer-stage-at-diagnosis-impacts-nhs-hospital-care-costs/)
- [Endometrial Cancer Audit Pilot (ECAP) Treatment Report published](https://healthdatainsight.org.uk/endometrial-cancer-audit-pilot-ecap-treatment-report-published/)
- [Launching the new Design System Gem](https://healthdatainsight.org.uk/launching-the-new-design-system-gem/)
- [A Review of Synthetic Data Terminology for Privacy Preserving Use Cases](https://healthdatainsight.org.uk/a-review-of-synthetic-data-terminology-for-privacy-preserving-use-cases/)
- [HDI Summer Internship 2026 Applications Now Open](https://healthdatainsight.org.uk/hdi-summer-internship-2026-applications-now-open/)
- [HDI Internship Programme](https://healthdatainsight.org.uk/hdi-internship-programme/)
- [Results from the PCCRC audit have been published](https://healthdatainsight.org.uk/results-from-the-pccrc-audit-have-been-published/)
- [Synthetic Data Demonstrates Major Benefits for Cancer Research](https://healthdatainsight.org.uk/synthetic-data-demonstrates-major-benefits-for-cancer-research/)
- [Long-term health outcomes of bilateral salpingo-oophorectomy in BRCA1 and BRCA2 pathogenic variant carriers with personal history of breast cancer: a retrospective cohort study using linked electronic health records](https://healthdatainsight.org.uk/long-term-health-outcomes-of-bilateral-salpingo-oophorectomy-in-brca1-and-brca2-pathogenic-variant-carriers-with-personal-history-of-breast-cancer-a-retrospective-cohort-study-using-linked-electronic/)
- [Leveraging Synthetic Data to Facilitate Research: A Collaborative Model for Analyzing Sensitive National Cancer Registry Data in England](https://healthdatainsight.org.uk/leveraging-synthetic-data-to-facilitate-research-a-collaborative-model-for-analyzing-sensitive-national-cancer-registry-data-in-england/)
- [Post Endoscopy Upper Gastrointestinal Cancer (PEUGIC) presentations at ESGE days 2025](https://healthdatainsight.org.uk/post-endoscopy-upper-gastrointestinal-cancer-peugic-presentations-at-esge-days-2025/)
- [The causes of post endoscopy upper gastrointestinal cancer in patients undergoing surveillance endoscopy: results from the English National Root Cause Analysis project.](https://healthdatainsight.org.uk/the-causes-of-post-endoscopy-upper-gastrointestinal-cancer-in-patients-undergoing-surveillance-endoscopy-results-from-the-english-national-root-cause-analysis-project/)
- [New study investigates long-term health risks after ovary and fallopian tube removal in women with previous history of breast cancer](https://healthdatainsight.org.uk/new-study-investigates-long-term-health-risks-after-ovary-and-fallopian-tube-removal-in-women-with-previous-history-of-breast-cancer/)
- [Organisational factors and Post Endoscopy Upper Gastrointestinal Cancer (PEUGIC): results of the English national PEUGIC project.](https://healthdatainsight.org.uk/organisational-factors-and-post-endoscopy-upper-gastrointestinal-cancer-peugic-results-of-the-english-national-peugic-project/)
- [First Endometrial Cancer Audit Pilot (ECAP) Report Published](https://healthdatainsight.org.uk/first-endometrial-cancer-audit-pilot-ecap-report-published/)
- [The causes of Post Endoscopy Upper Gastrointestinal Cancer: results from the English national root cause analysis project](https://healthdatainsight.org.uk/the-causes-of-post-endoscopy-upper-gastrointestinal-cancer-results-from-the-english-national-root-cause-analysis-project/)
- [The causes of Post Endoscopy Upper Gastrointestinal Cancer in patients undergoing diagnostic endoscopy](https://healthdatainsight.org.uk/the-causes-of-post-endoscopy-upper-gastrointestinal-cancer-in-patients-undergoing-diagnostic-endoscopy/)
- [First-line treatment patterns and overall survival in patients diagnosed with metastatic Merkel cell carcinoma in England from 2013 to 2020: results of a nationwide observational cohort study.](https://healthdatainsight.org.uk/first-line-treatment-patterns-and-overall-survival-in-patients-diagnosed-with-metastatic-merkel-cell-carcinoma-in-england-from-2013-to-2020-results-of-a-nationwide-observational-cohort-study/)
- [Long-term outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer](https://healthdatainsight.org.uk/long-term-outcomes-of-bilateral-salpingo-oophorectomy-in-women-with-personal-history-of-breast-cancer/)
- [Second Primary Cancer Risks After Breast Cancer in BRCA1 and BRCA2 Pathogenic Variant Carriers](https://healthdatainsight.org.uk/second-primary-cancer-risks-after-breast-cancer-in-brca1-and-brca2-pathogenic-variant-carriers/)
- [Treatment patterns and clinical outcomes in patients with metastatic urothelial carcinoma in England: A retrospective observational study](https://healthdatainsight.org.uk/treatment-patterns-and-clinical-outcomes-in-patients-with-metastatic-urothelial-carcinoma-in-england-a-retrospective-observational-study/)
- [Multiple Myeloma – Real-World Insights from nationally collected cancer data](https://healthdatainsight.org.uk/multiple-myeloma-real-world-insights-from-nationally-collected-cancer-data/)
- [Endometrial Cancer treatment and survival study published in BMJ Open](https://healthdatainsight.org.uk/endometrial-cancer-treatment-and-survival-study-published-in-bmj-open/)
- [Characteristics, Treatment Patterns, and Survival of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma in England: Results of a Nationwide Cohort Study.](https://healthdatainsight.org.uk/characteristics-treatment-patterns-and-survival-of-patients-with-locally-advanced-or-metastatic-renal-cell-carcinoma-in-england-results-of-a-nationwide-cohort-study/)
- [Ioana Preda](https://healthdatainsight.org.uk/ioana-preda/)
- [Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in England](https://healthdatainsight.org.uk/real-world-characteristics-and-outcomes-of-patients-with-multiple-myeloma-receiving-second-line-treatment-in-england/)
- [Real-world patient characteristics and survival outcomes in patients with advanced or recurrent endometrial cancer in England: a retrospective, population-based study](https://healthdatainsight.org.uk/real-world-patient-characteristics-and-survival-outcomes-in-patients-with-advanced-or-recurrent-endometrial-cancer-in-england-a-retrospective-population-based-study/)
- [Study reveals variability in kidney cancer treatment and survival](https://healthdatainsight.org.uk/study-reveals-variability-in-kidney-cancer-treatment-and-survival/)
- [2024 interns prototype a low-cost and low-tech solution to track hospital equipment location and status](https://healthdatainsight.org.uk/2024-internship-news/)
- [Analysis of patients in England with advanced urothelial carcinoma suggests high unmet need](https://healthdatainsight.org.uk/analysis-of-patients-in-england-with-advanced-urothelial-carcinoma-suggests-high-unmet-need/)
- [Variability in Kidney Cancer Treatment and Survival in England](https://healthdatainsight.org.uk/variability-in-kidney-cancer-treatment-and-survival-in-england/)
- [New partnership to assess variation in the management and outcomes of endometrial cancer](https://healthdatainsight.org.uk/new-partnership-to-assess-variation-in-the-management-and-outcomes-of-endometrial-cancer/)
- [Factors associated with receipt of systemic anticancer treatment for locally advanced or metastatic urothelial carcinoma in England: a population-based study](https://healthdatainsight.org.uk/factors-associated-with-receipt-of-systemic-anticancer-treatment-for-locally-advanced-or-metastatic-urothelial-carcinoma-in-england-a-population-based-study/)
- [PEUGIC data collection – an amazing collaborative achievement!](https://healthdatainsight.org.uk/peugic-data-collection-an-amazing-collaborative-achievement/)
- [A comparison of frailty measures in population-based data for patients with colorectal cancer](https://healthdatainsight.org.uk/a-comparison-of-frailty-measures-in-population-based-data-for-patients-with-colorectal-cancer/)
- [Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study](https://healthdatainsight.org.uk/risks-of-second-primary-cancers-among-584965-female-and-male-breast-cancer-survivors-in-england-a-25-year-retrospective-cohort-study/)
- [Melissa Gannon](https://healthdatainsight.org.uk/melissa-gannon/)
- [Merkel cell carcinoma poster presented at ESMO Congress 2023](https://healthdatainsight.org.uk/merkel-cell-carcinoma-poster-presented-at-esmo-congress-2023/)
- [Nicholas Robinson](https://healthdatainsight.org.uk/nicholas-robinson/)
- [The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource](https://healthdatainsight.org.uk/the-comprehensive-english-national-lynch-syndrome-registry-development-and-description-of-a-new-genomics-data-resource/)
- [Identification of people with Lynch syndrome from those presenting with colorectal cancer in England: baseline analysis of the diagnostic pathway](https://healthdatainsight.org.uk/identification-of-people-with-lynch-syndrome-from-those-presenting-with-colorectal-cancer-in-england-baseline-analysis-of-the-diagnostic-pathway/)
- [Simulacrum version 2 - unlocking cancer data with a richer view of treatment pathways](https://healthdatainsight.org.uk/simulacrum-version-2-unlocking-cancer-data-with-a-richer-view-of-treatment-pathways/)
- [Cohort study to assess geographical variation in cholangiocarcinoma treatment in England](https://healthdatainsight.org.uk/cohort-study-to-assess-geographical-variation-in-cholangiocarcinoma-treatment-in-england/)
- [HDI data analysts publish paper on geographical variation in cholangiocarcinoma treatment in England](https://healthdatainsight.org.uk/hdi-data-analysts-publish-paper-on-geographical-variation-in-cholangiocarcinoma-treatment-in-england/)
- [PEUGIC portal is now live!](https://healthdatainsight.org.uk/peugic-portal-is-now-live/)
- [Real-world evidence for patient outcomes and mutational burden in non-small cell lung (NSCLC) cancer patients in England using EGFR biomarker test data from routine clinical care](https://healthdatainsight.org.uk/real-world-evidence-for-patient-outcomes-and-mutational-burden-in-non-small-cell-lung-nsclc-cancer-patients-in-england-using-egfr-biomarker-test-data-from-routine-clinical-care/)
- [Real-world outcomes and biomarker testing in cancer patients: exploration of a novel genetic database from routine clinical practice in England](https://healthdatainsight.org.uk/real-world-outcomes-and-biomarker-testing-in-cancer-patients-exploration-of-a-novel-genetic-database-from-routine-clinical-practice-in-england/)
- [First-line treatment patterns and overall survival of patients with advanced Merkel cell carcinoma in England from 2013-2022: Results of a nationwide observational cohort study](https://healthdatainsight.org.uk/first-line-treatment-patterns-and-overall-survival-of-patients-with-advanced-merkel-cell-carcinoma-in-england-from-2013-2022-results-of-a-nationwide-observational-cohort-study-2/)
- [First-line treatment patterns and overall survival of patients with advanced Merkel cell carcinoma in England from 2013-2022: results of a nationwide observational cohort study](https://healthdatainsight.org.uk/first-line-treatment-patterns-and-overall-survival-of-patients-with-advanced-merkel-cell-carcinoma-in-england-from-2013-2022-results-of-a-nationwide-observational-cohort-study/)
- [Filis Liu](https://healthdatainsight.org.uk/filis-liu/)
- [HDI data analysts support the AMMF Cholangiocarcinoma Data Project](https://healthdatainsight.org.uk/hdi-data-analysts-support-the-ammf-cholangiocarcinoma-data-project/)
- [2023 Interns develop low-cost solutions to equipment tracking and people navigation in hospital settings](https://healthdatainsight.org.uk/2023-interns-develop-low-cost-solutions-to-equipment-tracking-and-people-navigation-in-hospital-settings/)
- [Evidence into practice: a national cohort study of NICE-recommended oncological drug therapy utilisation among women diagnosed with invasive breast cancer in England](https://healthdatainsight.org.uk/evidence-into-practice-a-national-cohort-study-of-nice-recommended-oncological-drug-therapy-utilisation-among-women-diagnosed-with-invasive-breast-cancer-in-england/)
- [P47 Treatment pathways of patients diagnosed with hepatocellular carcinoma (HCC) after initial locoregional treatment in England](https://healthdatainsight.org.uk/p47-treatment-pathways-of-patients-diagnosed-with-hepatocellular-carcinoma-hcc-after-initial-locoregional-treatment-in-england/)
- [Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis](https://healthdatainsight.org.uk/estimating-surgery-radiotherapy-and-systemic-anti-cancer-therapy-treatment-costs-for-cancer-patients-by-stage-at-diagnosis/)
- [Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer](https://healthdatainsight.org.uk/outcomes-of-dostarlimab-versus-chemotherapy-in-post-platinum-patients-with-recurrent-advanced-endometrial-cancer/)
- [Treatments into Routine Clinical Practice for the Treatment of Patients with Advanced or Metastatic Cancers](https://healthdatainsight.org.uk/treatments-into-routine-clinical-practice-for-the-treatment-of-patients-with-advanced-or-metastatic-cancers/)
- [Completeness of endocrine therapy information in the Primary Care Prescription Database (PCPD) and secondary care treatment datasets: A national population-based cohort study using routine healthcare data](https://healthdatainsight.org.uk/completeness-of-endocrine-therapy-information-in-the-primary-care-prescription-database-pcpd-and-secondary-care-treatment-datasets-a-national-population-based-cohort-study-using-routine-healthcare/)
- [PEUGIC portal piloted by 13 NHS organisations to enhance endoscopy quality](https://healthdatainsight.org.uk/peugic-portal-piloted-by-13-nhs-organisations-to-enhance-endoscopy-quality/)
- [Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017](https://healthdatainsight.org.uk/regional-variation-in-routes-to-diagnosis-of-cholangiocarcinoma-in-england-from-2006-to-2017/)
- [Variation in Rates of Post-Mastectomy Radiotherapy Among Women with Early Invasive Breast Cancer in England and Wales: A Population-Based Cohort Study.](https://healthdatainsight.org.uk/variation-in-rates-of-post-mastectomy-radiotherapy-among-women-with-early-invasive-breast-cancer-in-england-and-wales-a-population-based-cohort-study/)
- [Innovative Insights and Collaborative Spirit: Highlights from the 2023 HDI Symposium](https://healthdatainsight.org.uk/innovative-insights-and-collaborative-spirit-highlights-from-the-2023-hdi-symposium/)
- [Roger Cherry](https://healthdatainsight.org.uk/roger-cherry/)
- [Clinical characteristics, treatments and outcomes in patients diagnosed with hepatocellular carcinoma (HCC) receiving locoregional treatment in England](https://healthdatainsight.org.uk/clinical-characteristics-treatments-and-outcomes-in-patients-diagnosed-with-hepatocellular-carcinoma-hcc-receiving-locoregional-treatment-in-england/)
- [Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018](https://healthdatainsight.org.uk/sebaceous-carcinoma-epidemiology-associated-malignancies-and-lynch-muir-torre-syndrome-screening-in-england-from-2008-to-2018/)
- [Long-term health outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer](https://healthdatainsight.org.uk/long-term-health-outcomes-of-bilateral-salpingo-oophorectomy-in-women-with-personal-history-of-breast-cancer/)
- [Amivantamab Versus Alternative Real-World Anti-Cancer Therapies in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in the US and Europe](https://healthdatainsight.org.uk/amivantamab-versus-alternative-real-world-anti-cancer-therapies-in-patients-with-advanced-non-small-cell-lung-cancer-with-epidermal-growth-factor-receptor-exon-20-insertion-mutations-in-the-us-and-eur/)
- [HDI Symposium requirements](https://healthdatainsight.org.uk/hdi-symposium-requirements/)
- [Trends in incidence, treatment and survival of Merkel cell carcinoma epidemiology in England 2004-2018](https://healthdatainsight.org.uk/trends-in-incidence-treatment-and-survival-of-merkel-cell-carcinoma-epidemiology-in-england-2004-2018/)
- [An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations](https://healthdatainsight.org.uk/an-adjusted-treatment-comparison-comparing-amivantamab-versus-real-world-clinical-practice-in-europe-and-the-united-states-for-patients-with-advanced-non-small-cell-lung-cancer-with-activating-epiderm/)
- [Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996–2020](https://healthdatainsight.org.uk/germline-mismatch-repair-mmr-gene-analyses-from-english-nhs-regional-molecular-genomics-laboratories-1996-2020/)
- [Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia.](https://healthdatainsight.org.uk/cohort-profile-of-the-sloane-project-methodology-for-a-prospective-uk-cohort-study-of-15-000-women-with-screen-detected-non-invasive-breast-neoplasia/)
- [Second primary cancer risks for female and male breast cancer survivors](https://healthdatainsight.org.uk/second-primary-cancer-risks-for-female-and-male-breast-cancer-survivors/)
- [Amivantimab versus real-world clinical practice in Europe and the US for patients with advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations](https://healthdatainsight.org.uk/amivantimab-versus-real-world-clinical-practice-in-europe-and-the-us-for-patients-with-advanced-non-small-cell-lung-cancer-with-activating-epidermal-growth-factor-receptor-exon-20-insertion-mutations/)
- [Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England](https://healthdatainsight.org.uk/characteristics-treatment-patterns-and-outcomes-of-patients-with-newly-diagnosed-advanced-ovarian-cancer-aoc-in-england/)
- [The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project.](https://healthdatainsight.org.uk/the-presentation-management-and-outcome-of-patients-with-ductal-carcinoma-in-situ-dcis-with-microinvasion-invasion-%e2%89%a41-mm-in-size-results-from-the-uk-sloane-project/)
- [2022 Interns work on improving patient flow in a hospital setting](https://healthdatainsight.org.uk/2022-interns-work-on-improving-patient-flow-in-a-hospital-setting/)
- [Change in the Use of Fractionation in Radiotherapy Used for Early Breast Cancer at the Start of the COVID-19 Pandemic](https://healthdatainsight.org.uk/change-in-the-use-of-fractionation-in-radiotherapy-used-for-early-breast-cancer-at-the-start-of-the-covid-19-pandemic/)
- [Factors associated with the receipt of systemic treatment (tx) for metastatic urothelial carcinoma (mUC) in England](https://healthdatainsight.org.uk/factors-associated-with-the-receipt-of-systemic-treatment-tx-for-metastatic-urothelial-carcinoma-muc-in-england/)
- [Evolution of the treatment landscape in patients with advanced or metastatic cancers following the approval of immuno-oncology treatments](https://healthdatainsight.org.uk/evolution-of-the-treatment-landscape-in-patients-with-advanced-or-metastatic-cancers-following-the-approval-of-immuno-oncology-treatments/)
- [Previously treated recurrent or advanced endometrial cancer in England: a real-world observational analysis](https://healthdatainsight.org.uk/previously-treated-recurrent-or-advanced-endometrial-cancer-in-england-a-real-world-observational-analysis/)
- [Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.](https://healthdatainsight.org.uk/genomic-analysis-defines-clonal-relationships-of-ductal-carcinoma-in-situ-and-recurrent-invasive-breast-cancer/)
- [Kidney Cancer UK Quality Performance Audit of Kidney Cancer Services in England](https://healthdatainsight.org.uk/kidney-cancer-uk-quality-performance-audit-of-kidney-cancer-services-in-england/)
- [Comparison of survival outcomes between dostarlimab and comparator treatments (tx) in patients (pts) with advanced/recurrent (A/R) endometrial cancer (EC) in England](https://healthdatainsight.org.uk/comparison-of-survival-outcomes-between-dostarlimab-and-comparator-treatments-tx-in-patients-pts-with-advanced-recurrent-a-r-endometrial-cancer-ec-in-england/)
- [An overview on synthetic administrative data for research](https://healthdatainsight.org.uk/an-overview-on-synthetic-administrative-data-for-research/)
- [Short-term mortality in ovarian, fallopian tube ad primary peritoneal carcinomas across England](https://healthdatainsight.org.uk/short-term-mortality-in-ovarian-fallopian-tube-ad-primary-peritoneal-carcinomas-across-england/)
- [Lisa Franklin](https://healthdatainsight.org.uk/lisa-franklin/)
- [Rebeca Fiadeiro](https://healthdatainsight.org.uk/rebeca-fiadeiro/)
- [Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study).](https://healthdatainsight.org.uk/breast-screening-atypia-and-subsequent-development-of-cancer-protocol-for-an-observational-analysis-of-the-sloane-database-in-england-sloane-atypia-cohort-study/)
- [Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study.](https://healthdatainsight.org.uk/unresected-screen-detected-ductal-carcinoma-in-situ-outcomes-of-311-women-in-the-forget-me-not-2-study/)
- [Artificial Intelligence in Drug Design: Opportunities and Challenges](https://healthdatainsight.org.uk/artificial-intelligence-in-drug-design-opportunities-and-challenges/)
- [2021 interns create TheatreCapture](https://healthdatainsight.org.uk/2021-interns-create-theatrecapture/)
- [Demographics and survival outcomes in patients with advanced or recurrent endometrial cancer (EC) following platinum-based doublet (PBD) in the English real-world (RW) setting](https://healthdatainsight.org.uk/demographics-and-survival-outcomes-in-patients-with-advanced-or-recurrent-endometrial-cancer-ec-following-platinum-based-doublet-pbd-in-the-english-real-world-rw-setting/)
- [A registry study of relapsed or refractory multiple myeloma pre-exposed to 3 or more therapies including a proteasome inhibitor, an immunomodulatory agent and cd38-targeted monoclonal antibody therapy in England](https://healthdatainsight.org.uk/a-registry-study-of-relapsed-or-refractory-multiple-myeloma-pre-exposed-to-3-or-more-therapies-including-a-proteasome-inhibitor-an-immunomodulatory-agent-and-cd38-targeted-monoclonal-antibody-therapy/)
- [Clare Pearson](https://healthdatainsight.org.uk/clare-pearson/)
- [Surgical decisions in older women with early breast cancer: patient and disease factors](https://healthdatainsight.org.uk/surgical-decisions-in-older-women-with-early-breast-cancer-patient-and-disease-factors/)
- [Updated version of Simulacrum released](https://healthdatainsight.org.uk/updated-version-of-simulacrum-released/)